Chlamydia/Neisseria gonorrhoeae RNA, TMA, Urogenital
Test Code: 11363
CPT Codes: 87494
Test Code: 11363
CPT Codes: 87494
Test Code: 10121
CPT Code(s): 87481 (x2) *CPT coding may differ dependent on payer rules which may impact prior authorization testing. Please direct any questions regarding CPT coding to the payer being billed.
Test Code: 10029
CPT Code(s): 87481 (x2), 87661 *CPT coding may differ dependent on payer rules which may impact prior authorization testing. Please direct any questions regarding CPT coding to the payer being billed.
Test Code: 10119
CPT Code(s): 81513, 87481 (x2), 87661 *CPT coding may differ dependent on payer rules which may impact prior authorization testing. Please direct any questions regarding CPT coding to the payer being billed.
Test Code: 10123
CPT Code(s): 87494, 81513 *CPT coding may differ dependent on payer rules which may impact prior authorization testing.
Please direct any questions regarding CPT coding to the payer being billed.
Test Code: 10016
CPT Code: 81513
Breast Plus Panel without BRCA (TP53, STK11, PTEN, CDH1, PALB2)
Test Code: 92586
CPT Code(s): 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479
Clinical Significance: CDH1, PALB2, PTEN, STK11 and TP53 are tumor suppressor genes, where inherited mutations significantly increase breast cancer risk. Sequence analysis and deletion/duplication analysis of these five genes can explain an additional 3% to 4.5% of hereditary breast cancers.
Test Code: 92573
CPT Code(s): 81162
Includes: If the Interpretation Summary is not one of the following three results: Positive for a known Pathogenic Mutation; Positive for a likely Pathogenic Mutation; Positive for a likely Pathogenic Mutation and a variant with unknown significance, then TP53, PTEN, CDH1, STK11, and PALB2 will be performed at an additional charge (CPT code(s) 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479).